Analysis of predisposing factors and drug resistance of urinary tract infection with extended-spectrum beta-lactamase producing Escherichia Coli
- VernacularTitle:产超广谱β-内酰胺酶大肠埃希菌尿路感染易感因素及耐药分析
- Author:
Peifang ZHOU
;
Juanjuan LU
;
Peifen WANG
- Publication Type:Journal Article
- Keywords:
Urinary tract infection;
Escherichia;
Beta-lactam resistance
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(4):554-555
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the predisposing factors of urinary tract infection(UTI) with extendedspectrum beta-lactaraase(ESBLs) producing Escherichia Coli(E. coli) and its resistance to antimicrobial agents.Methods 26 cases of UTI patients with ESBLs producing E. coli from 2003 to 2005 in our hospital were analyzed retrospectively and compared with the ESBLs non-producing strains. Results 88.5 % of the patients with UTI in ESBLs producing E. coli had received broad-spectrum antimierobial therapy before the diagnosis, 69.2 % of the patients were complicate UTIS, 42.3 % of the patients experienced invasive operations in urinary tract; the incidence of drug resistance of ESBLs producing bacteria to the second, third-generation cephalosporins and quinolone was significantly higher than that of ESBLs non-producing bacteria, but it was highly sensitive to imipenem. Conclusion The drug resistance of ESBLs producing E. coli is severe gradually. So much attention should be paid to the ESBLs producing bacteria detection in UTIs. Antimicrobial therapy should be initiated under the guidance of drug sensitivity test,it is necessary to rid the predisposing factors of UITs as much as possible in order to decrease ESBLs-producing bacteria infection.
